Novavax NVAX Business Segments — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's business segments — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's business segments — total revenue?
- Novavax (NVAX) reported business segments — total revenue of $139.51M in Q1 2026.
- How has Novavax's business segments — total revenue changed year-over-year?
- Novavax's business segments — total revenue decreased by 79.1% year-over-year, from $666.66M to $139.51M.
- What is the long-term trend for Novavax's business segments — total revenue?
- Over 3 years (2022 to 2025), Novavax's business segments — total revenue has grown at a -17.2% compound annual growth rate (CAGR), from $1.98B to $1.12B.
- What does business segments — total revenue mean?
- Represents the total gross income generated by the company's primary reportable business segment through the sale of products and services. This metric reflects the market demand for the segment's offerings and serves as a key indicator of its top-line growth and commercial performance.